{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL1096&max-date=2018-06-12", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=HL1096&max-date=2018-06-12", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL1096&max-date=2018-06-12&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=HL1096&max-date=2018-06-12", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL1096&max-date=2018-06-12", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL1096&max-date=2018-06-12", "items" : [{"_about" : "http://data.parliament.uk/resources/753950", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/753950/answer", "answerText" : {"_value" : "

The Department for Exiting the EU is working with officials across government and undertaking a programme of analytical work to assess the economic impacts of exiting the European Union across a range of scenarios.<\/p>

As part of our analysis we are looking at more than 50 sectors within the areas of goods; services; financial services; network industries; and agriculture and fisheries as well as cross-cutting regulations. This will inform the UK's position for the negotiations with our EU partners.<\/p>

However, Parliament has asked the Government to protect information that could undermine the UK's negotiating position and the Government will respect this.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3474", "label" : {"_value" : "Biography information for Baroness Anelay of St Johns"} } , "answeringMemberPrinted" : {"_value" : "Baroness Anelay of St Johns"} , "dateOfAnswer" : {"_value" : "2017-08-02", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-08-02T14:44:08.883Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "203"} , "answeringDeptShortName" : {"_value" : "Exiting the European Union"} , "answeringDeptSortName" : {"_value" : "Exiting the European Union"} , "date" : {"_value" : "2017-07-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Service Industries: UK Trade with EU"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "Her Majesty's Government what assessment they have made of the impact of relying on agreements under the WTO for trade with the EU27 should an agreement with the EU not be reached by April 2019 in the following services sectors: (1) financial services, (2) professional business services, (3) digital services, (4) creative services, (5) air services, (6) tourism, (7) education, and (8) health-related travel services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4284", "label" : {"_value" : "Biography information for Baroness Neville-Rolfe"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Neville-Rolfe"} ], "uin" : "HL1096"} , {"_about" : "http://data.parliament.uk/resources/535100", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/535100/answer", "answerText" : {"_value" : "

The noble Lord appears to be referring to the recent work by Latorre-Pellicer et al (2016). The Human Fertilisation and Embryology Authority (HFEA) has advised that this research will be considered by the reconvened Expert Panel which will assess the safety and efficacy of mitochondrial donation techniques more widely.<\/p>

<\/p>

The guidance referred to by the noble Lord refers to haplotype matching in the provision of mitochondrial donation treatment. At present, no clinics in the United Kingdom are licenced to provide such treatment. The HFEA has further advised that the research published in Nature<\/em> is consistent with that guidance. The HFEA will continue to advise clinics to keep themselves up to date with the scientific research in this area.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2016-07-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-25T10:40:49.81Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-07-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what assessment the Human Fertilisation and Embryology Authority (HFEA) has made of research published in Nature<\/i> regarding mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing; and how that assessment relates to the recommendations contained within guidance note 33.23 on the HFEA website.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL1096"} , {"_about" : "http://data.parliament.uk/resources/387719", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/387719/answer", "answerText" : {"_value" : "

The Department has not received any specific representations from Monitor regarding increasing the number of training places for doctors and nurses.<\/p>

<\/p>

<\/strong><\/p>

<\/p>

Health Education England (HEE) is responsible for workforce planning for the National Health Service and as part of that process liaise with all arms length bodies, including Monitor, individual healthcare providers and key stakeholders regards medical and non medical staffing requirements going forward.<\/p>

<\/p>

<\/p>

<\/p>

The Department set up HEE to deliver a better health and healthcare workforce for England. HEE is responsible for ensuring a secure workforce supply for the future balancing need against demand, taking into account factors such as the age profile of the existing workforce, the impact of technology, and new drugs.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2015-07-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-07-20T10:41:02.703Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-07-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Professions: Training"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what representations they have received from Monitor regarding the case for increasing training places for doctors and nurses since 2010.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL1096"} , {"_about" : "http://data.parliament.uk/resources/77799", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/77799/answer", "answerText" : {"_value" : "

Neurofibromatosis Type 1 (NF1) patients are included within the remit of Dr David Bateman in his role as National Clinical Director for Chronic Disability and Neurological Conditions at NHS England.<\/p>

<\/p>

There are currently no plans for awareness raising activity in relation to NF 1, which is an inherited condition. Information for the public on the diagnosis and treatment of NF1 can be found on the NHS Choices website, which sets out the key signs and symptoms of the condition, including: coffee colored patches on the skin, two or more neurofibromas (bumps on or under the skin); bone defects, such as bowing of the lower leg; and, a family history of NF1. The NF1 webpages can be viewed at the following link:<\/p>

<\/p>

www.nhs.uk/conditions/Neurofibromatosis/Pages/Introduction.aspx.<\/p>

<\/p>

More detailed information for general practitioners and other health professionals can be found on the National Institute for Health and Care Excellence NHS Evidence website:<\/p>

<\/p>

www.evidence.nhs.uk.<\/p>

<\/p>

This provides free access to quality health and social care evidence and best practice.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2014-07-22", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL1093"} , {"_value" : "HL1094"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-07-22T16:22:10.7390499Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-07-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Neurofibromatosis"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what plans they have to increase awareness amongst midwives and general practitioners of neurofibromatosis Type 1.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL1096"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 4, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }